微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 14.5% | 13.28% | 91.29% | 6/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 7.58% | 1.61% | 22.26% | 18/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 6.2% | 43.85% | -44.29% | 5/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 11.13% | 88.96% | -13.05% | 25/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 12.8% | 59.4% | 71.58% | 14/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 7.46% | 65.41% | 73.09% | 21/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 4.31% | 24.93% | -26.83% | 10/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 5.89% | -48.6% | -26.65% | 55/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 8.03% | -34.34% | 78.05% | 39/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 4.51% | -32.49% | 30.72% | 47/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 3.45% | -41.03% | -69.9% | 28/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 11.46% | 92.61% | -6.3% | 35/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 12.23% | 35.74% | 83.08% | 20/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 6.68% | 70.84% | 14.19% | 28/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 5.85% | 126.74% | -1.68% | 8/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 5.95% | -20.67% | -33.96% | 71/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 9.01% | 35.69% | 130.43% | 42/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 3.91% | 72.25% | 51.55% | 69/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 2.58% | 336.7% | -65.6% | 52/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 7.5% | -5.9% | 12.95% | 71/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 6.64% | -25.31% | 192.51% | 61/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.27% | -49.67% | 308.26% | 84/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | -1.09% | -131.41% | -113.68% | 96/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 7.97% | 83.22% | -10.35% | 70/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 8.89% | 4.83% | 97.12% | 40/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 4.51% | 6.12% | 29.97% | 54/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 3.47% | 2.36% | -20.23% | 29/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 4.35% | 20.17% | -48.7% | 94/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 8.48% | 18.11% | 99.53% | 36/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 4.25% | 4.94% | 25.37% | 52/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 3.39% | 17.3% | -6.35% | 21/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.62% | -32.34% | -49.58% | 94/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 7.18% | -9.34% | 77.28% | 47/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 4.05% | -1.22% | 40.14% | 62/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 2.89% | -4.93% | -45.98% | 28/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 5.35% | -33.54% | -32.45% | 80/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 7.92% | -15.11% | 93.17% | 35/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 4.1% | -5.75% | 34.87% | 45/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 3.04% | 6.67% | -62.24% | 28/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 8.05% | -5.41% | -13.72% | 56/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 9.33% | -11.06% | 114.48% | 30/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 4.35% | -20.04% | 52.63% | 41/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 2.85% | 19.25% | -66.51% | 32/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |